Keyphrases
Genotype
100%
Hepatitis B Virus DNA
100%
Chronic Hepatitis B
100%
Entecavir
100%
Pegylated Interferon alfa-2a
100%
Sequential Therapy
100%
Genotype E
60%
Monotherapy
40%
Treatment Strategy
40%
Hepatitis B Virus
40%
Viremia
40%
Sustained Virological Response
40%
Genotype A
40%
Response Rate
20%
Treatment Options
20%
Promising Strategies
20%
Hepatitis B
20%
Standard of Care
20%
Poor Response
20%
Pegylated Interferon
20%
Patient-controlled
20%
Hepatitis B Surface Antigen (HBsAg)
20%
Virological Response
20%
Seroconversion Rate
20%
Serological Response
20%
Sequential Approach
20%
Seroconversion
20%
Nucleos(t)ide Analogues
20%
Genotype B
20%
E-patient
20%
Anti-HBe
20%
Genotype C
20%
Medicine and Dentistry
Virus DNA
100%
Polyethylene Glycol
100%
Hepatitis B Virus
100%
Peginterferon Alpha
100%
Chronic Hepatitis B
100%
Entecavir
100%
Alpha2a Interferon
100%
Monotherapy
40%
Viremia
40%
Seroconversion
40%
Hepatitis B
20%
Peginterferon
20%
Hepatitis B(e) Antibody
20%
Hepatitis B Antibody
20%
Pharmacology, Toxicology and Pharmaceutical Science
Hepatitis B Virus
100%
Virus DNA
100%
Polyethylene Glycol
100%
Peginterferon Alpha
100%
Chronic Hepatitis B
100%
Entecavir
100%
Alpha2a Interferon
100%
Monotherapy
40%
Viremia
40%
Hepatitis B
20%
Peginterferon
20%
Hepatitis B(e) Antibody
20%
Hepatitis B Antibody
20%